RxDoctor Payments Data

Elizabeth Triana, MD

Family Medicine · Port Charlotte, FLNPI 1811929466

Payments from drug & device makers

$2,076in general payments, 2019–2025

Across 37 payments — averaging $56.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$331
  • GSK$238
  • AstraZeneca$211
  • Novo Nordisk$196
  • Pfizer$166
  • E.r. Squibb & Sons, L.L.C.$124
  • plus $809 from 12 others

What the payments were for

  • Food & beverage$2,076100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,076 in reported general payments places this provider in the 75th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$64,626
Medicare patients
116
Services billed
555

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide11$11,827
Spiriva HandihalerTiotropium Bromide11$5,669
Rosuvastatin Calcium95$1,535
Levothyroxine Sodium109$1,154
Np ThyroidThyroid,pork16$1,147
Losartan Potassium70$949
Estradiol (Twice Weekly)Estradiol13$918
Ezetimibe38$904
ProgesteroneProgesterone, Micronized21$649
SynthroidLevothyroxine Sodium12$646
Simvastatin37$625
Metoprolol Succinate46$613
Atorvastatin Calcium70$505
Pantoprazole Sodium13$478
Zolpidem Tartrate36$473

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$22$11,82711 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Port Charlotte

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →